ESSA Pharma Inc. (EPIX)

ESSA Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 4, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Market Capitalization	72	136	80	352	200	70
Market Cap Growth	96.01%	69.89%	-77.20%	75.80%	186.07%	303.65%
Enterprise Value	-58	-16	-94	150	164	69
Last Close Price	1.63	3.09	1.82	8.00	6.90	3.37
PE Ratio	-	-5.13	-2.28	-8.36	-6.61	-2.23
PB Ratio	0.56	0.94	0.48	1.81	2.53	1.43
P/FCF Ratio	-9.79	-6.89	-2.86	-13.84	-11.79	-5.71
P/OCF Ratio	-9.79	-6.89	-2.86	-13.84	-11.79	-5.71
EV/EBITDA Ratio	-	-	-	-	-6.97	-5.73
EV/EBIT Ratio	-2.89	0.50	2.55	-4.04	-6.96	-5.72
EV/FCF Ratio	-4.10	0.81	3.36	-5.90	-9.64	-5.67
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.08
Debt / FCF Ratio	-0.01	0.00	-0.01	-0.01	0.00	-0.30
Quick Ratio	36.61	42.41	72.39	49.73	65.35	9.63
Current Ratio	36.95	42.57	73.17	50.28	66.73	9.74
Return on Equity (ROE)	-19.83%	-17.00%	-19.44%	-26.94%	-36.57%	-43.89%
Return on Assets (ROA)	-14.79%	-12.61%	-12.57%	-16.66%	-21.75%	-21.52%
Return on Capital (ROIC)	-15.15%	-12.83%	-12.77%	-16.97%	-22.27%	-22.28%
Earnings Yield	-38.26%	-19.51%	-43.76%	-10.46%	-11.71%	-18.23%
FCF Yield	-32.96%	-14.52%	-34.91%	-7.22%	-8.48%	-17.51%
Buyback Yield / Dilution	-0.28%	-0.12%	-14.44%	-71.45%	-166.13%	-84.68%
Total Shareholder Return	-0.28%	-0.12%	-14.44%	-71.45%	-166.13%	-84.68%

Source: S&P Capital IQ. Standard template. Financial Sources.